These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7919108)

  • 1. Involvement of alpha-interferon in HIV-1 induced immunosuppression. A potential target for AIDS prophylaxis and treatment.
    Lachgar A; Bizzini B
    Biomed Pharmacother; 1994; 48(2):73-7. PubMed ID: 7919108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of alpha interferon (alpha IFN) to HIV-induced immunosuppression.
    Lachgar A; Bizzini B
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):431-7. PubMed ID: 7580838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodies.
    Lachgar A; Bernard J; Bizzini B; Astgen A; Le Coq H; Fouchard M; Chams V; Feldman M; Burny A; Zagury JF
    Biomed Pharmacother; 1996; 50(1):13-8. PubMed ID: 8672726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Tat and IFN(alpha) as a therapeutic AIDS vaccine.
    Gallo RC; Burny A; Zagury D
    DNA Cell Biol; 2002 Sep; 21(9):611-8. PubMed ID: 12396603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Kinoids": the basis for anticytokine immunization and their use in HIV infection.
    Bizzini B; Achour A
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):351-6. PubMed ID: 7580827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.
    Capobianchi MR
    J Biol Regul Homeost Agents; 1996; 10(4):83-91. PubMed ID: 9604776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication.
    Francis ML; Meltzer MS
    J Immunol; 1993 Aug; 151(4):2208-16. PubMed ID: 8345204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of interleukin-4, interferon (IFN)-gamma and IFN-alpha in human immunodeficiency virus-1 infection: an imbalance of type 1 and type 2 cytokines may reduce the synthesis of IFN-alpha.
    Hober D; Benyoucef S; Chehadeh W; Chieux V; De La Tribonniere X; Mouton Y; Bocket L; Wattre P
    Scand J Immunol; 1998 Oct; 48(4):436-42. PubMed ID: 9790316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupled anti-HIV and immune-enhancing effects when combining IFN-alpha and IL-7.
    Audigé A; Schlaepfer E; Joller H; Speck RF
    J Immunol; 2005 Sep; 175(6):3724-36. PubMed ID: 16148118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice.
    Sanhadji K; Leissner P; Firouzi R; Pelloquin F; Kehrli L; Marigliano M; Calenda V; Ottmann M; Tardy JC; Mehtali M; Touraine JL
    AIDS; 1997 Jul; 11(8):977-86. PubMed ID: 9223731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C; Santini SM; Logozzi M; Spada M; Andreotti M; Di Pucchio T; Parlato S; Belardelli F
    J Exp Med; 2003 Jul; 198(2):361-7. PubMed ID: 12874266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro and in vivo inhibition of HIV1 replication by retroviral transfer of interferon alpha, beta, or gamma genes: application to gene therapy of AIDS].
    Leissner P; Calenda V; Marigliano M; Sanhadji K; Touraine JL; Pavirani A; Mehtali M
    Ann Biol Clin (Paris); 1998; 56(2):167-73. PubMed ID: 9754242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.
    de Castro Cunha RM; Kallas EG; Rodrigues DS; Nascimento Burattini M; Salomao R
    Clin Exp Immunol; 2005 Jun; 140(3):491-7. PubMed ID: 15932510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression.
    Stylianou E; Aukrust P; Müller F; Nordøy I; Frøland SS
    Cytokine; 2001 Apr; 14(1):56-62. PubMed ID: 11298493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV].
    Dianzani F; Capobianchi MR; De Marco F; Di Marco P; Gentile M; Antonelli G; Amicucci P; Cefaro A; Ruggiero V; Turriziani O
    Ann Ig; 1989; 1(3-4):647-60. PubMed ID: 2483637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effect of active anti-IFN alpha immunization in HIV-infected patients.
    Fall LS; M'Bika JP; Le Coq H; Fouchard M; Astgen A; Bizzini B; Gringeri A; Santagostino E; Burny A; Zagury D
    Biomed Pharmacother; 1995; 49(9):422-8. PubMed ID: 8746078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.
    Klein SA; Dobmeyer JM; Dobmeyer TS; Pape M; Ottmann OG; Helm EB; Hoelzer D; Rossol R
    AIDS; 1997 Jul; 11(9):1111-8. PubMed ID: 9233457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.